As the monthly member magazine of the American Academy of Ophthalmology, EyeNet combines the wide reach and authority of the Academy with quick and useful information that Academy members can immediately apply in patient care. With EyeNet Magazine at the center of your marketing plan, you are guaranteed a loyal and avid reader base. Build out from that core with EyeNet’s satellite offerings: AAO 2016 print and electronic publications, custom supplements offered throughout the year, and digital opportunities to engage your audience when and how they choose to read the magazine.
EyeNet tops the charts in both peer-reviewed and non-peer-reviewed publications. Among all ophthalmologists, EyeNet ranks:
- #1 in ad page exposures for the 2nd year in a row! Your ad has a higher chance of being seen in EyeNet than any other ophthalmic publication. EyeNet is at 38%—the next publication is at 28%.
- #1 in high readers for the 7th year in a row! EyeNet has the most dedicated readers—those who read with high frequency in high numbers.
- #1 in total readers for the 2nd year in a row! More readers recall reading EyeNet than any other ophthalmic publication.
- #1 in average page exposures for the 4th year in a row! More ophthalmologists will view any given page in EyeNet than in competing publications.
Source: Kantar Media 2015 Eyecare Readership Study, Tables 701 and 801.
Contact Kelly Miller or Mark Mrvica of M.J. Mrvica Associates at email@example.com or 856-768-9360.
AAO 2016 Opportunities
Space and Material Deadlines
2016 Editorial Calendar
Space and Material Deadlines
Ad Close: November 30
Materials Close: December 4
Ad Close: January 4
Materials Close: January 8
Ad Close: February 1
Materials Close: February 5
Ad Close: February 29
Materials Close: March 4
Ad Close: March 28
Materials Close: April 1
Ad Close: May 2.
Materials Close: May 6.
Ad Close: May 31.
Materials Close: June 3.
Ad Close: July 1
Materials Close: July 8
Ad Close: August 1
Materials Close: August 5
Ad Close: September 2
Materials Close: September 9
Ad Close: September 26
Materials Close: September 30
Ad Close: October 31
Materials Close: November 4
||15" x 10"
||16 1/2" x 11 1⁄8"
||7" x 10"
||8 3⁄8" x 11 1⁄8"
|1/2 page (horiz)
||7" x 4 3/4"
||8 3⁄8" x 5 1/2"
|1/2 page (vert)
||3 1/4" x 10"
||4 1/4" x 11 1⁄8"
|2/3 page (vert)
||4 1/2" x 10"
||5 3⁄8" x 11 1⁄8"
||3 1/4" x 4 3/4"
EyeNet Trim Size (Page): 8 1/8" x 10 7/8"
EyeNet Trim Size (Spread): 16 1/4" x 10 7/8"
Live Matter: Bleed sizes include 1/8" trim from outside, bottom, top, and gutter. Keep live matter 1/2" from trim size of page.
Digital Ad Requirements
High-resolution PDF is the preferred file format. These files (PDF/X-1a:2001) should be created using Adobe Acrobat Distiller 4.05 (or greater) or exported from Quark XPress or InDesign using the PDF/X-1a:2001 setting. All graphics and fonts must be embedded. Spot colors and RGB color should be converted to CMYK before creating the PDF. All trim and registration marks must appear outside the bleed area (1/8 inch from trim). Scanned images must be saved as high resolution (at least 266 dpi) in TIFF or EPS format.
TIFF and EPS files created with Illustrator or Photoshop are also acceptable. Supply both printer and screen fonts, including fonts embedded in art files. If submitting an InDesign document (CS4 or greater), you must supply all fonts and art files. Line art should be scanned at 600 dpi. Images (TIFF or EPS) should be at least 266 dpi and saved in CMYK mode.
Send the following:
- Ad file (high-resolution PDF or native files).
- Any supporting graphics that are incorporated in the ad (e.g., logo file, images).
- Screen and printer fonts. Fonts must still be included even if the ad is saved as an EPS file.
Ads can also be submitted via FTP. Materials should be placed within a folder titled with the company name and issue date. Email EyeNet at firstname.lastname@example.org when the ad is uploaded.
Server Address: ftp.aao.org
Password: provided by email@example.com
|Black and White
Cover and Other Special Rates
Cover 2: 35% over earned black-and-white rate.
Cover 3: 20% over earned black-and-white rate.
Cover 4: 50% over earned black-and-white rate.
Table of Contents: 15% over earned black-and white rate.
Opposite Editorial Board: 10% over earned black and-white rate.
2-Page Insert: Two times earned black-and white rate.
4-Page Insert: Four times earned black-and white rate.
Advertising Continuity Program: Advertise in three issues and earn a free ad of equal size in the third issue.
15% allowed to agencies of record, with billing to the agency. In-house agencies are acceptable.
2016 Editorial Calendar
Cardiovascular and Eye Diseases: Some cardiovascular and eye diseases share underlying risk factors and mechanisms. Recognizing and responding to these associations may have far-reaching implications for your patients.
Clinical Updates: Cataract, Glaucoma, Refractive
Distributed at WOC
Glaucoma Faces Pressure: Although high intraocular pressure is a common culprit in primary open-angle glaucoma, several other mechanisms are being explored. An in-depth look at the dynamics that may be at work in your glaucoma suspect and glaucoma patients.
Clinical Updates: Cornea , Neuro, Retina
Spotlight on Cataract: Revisiting the excitement from the Spotlight on Cataract session during AAO 2015, EyeNet presents a variety of surgical cases, along with audience poll questions and answers, and expert commentary.
Clinical Updates: Cornea, Oncology, Pediatrics
Distributed at APAO
A Report on Interoperability: An ophthalmic office’s diagnostic devices, image management software, and medical records are supposed to integrate seamlessly to improve efficiency—yet some doctors tell a different story.
Clinical Updates: Neuro, Trauma, Uveitis
Distributed at ASCRS and MEACO
Macular Edema: Steroids vs. Anti-VEGF Agents: New research has come to light about when to treat macular edema with steroids—instead of, or in addition to—anti-VEGF drugs. Experts discuss their experiences with the effectiveness and trade-offs of each approach.
Clinical Updates: Glaucoma, Pediatrics, Refractive
Destination AAO 2016, Part 1
Tele-ophthalmology: Telemedicine is a growing trend, with public and private insurance coverage now available in most states. Given the expansion of smartphone apps for ocular imaging—and the shortage of specialists in some areas —how will remote diagnosis and management affect ophthalmology?
Clinical Updates: Comprehensive, Oculoplastics, Retina
Destination AAO 2016, Part 2
Good Enough? Are you practicing substandard medicine if you don’t offer your patients the latest technology and procedures? A look at your responsibility to patients from both ethical and practical standpoints, with discussion of femto-cataract surgery, multifocal lenses, and more.
Clinical Updates: Cornea, Glaucoma, Oncology
Destination AAO 2016, Part 3
Bionic Eye: Several recent studies are bringing into focus the picture of where we are with retinal implants and how they are changing patients’ lives. An overview of the current status and future prospects for this technology.
Clinical Updates: Cataract, Comprehensive, Neuro
Destination AAO 2016, Part 4
Distributed at ASRS and ESCRS
Glaucoma in Children: A practical overview of pediatric glaucoma—from etiology and risk factors to examination techniques and beyond, including medical and surgical management. Experts discuss current best practices. Plus news on genetic testing and counseling.
Clinical Updates: Comprehensive, Cornea, Oncology
Destination AAO 2016, Part 5
October: AAO 2016 issue
Caring for the Elderly Patient: Aging patients often have complex comorbidities that affect ophthalmic care and adherence to treatment. And with people living longer than ever, ophthalmologists need to ensure their therapies can last a lifetime.
Clinical Updates: Cataract, Refractive, Retina
Destination AAO 2016, Part 6
Distributed at AAO 2016
Neuroimaging 101 for Ophthalmologists: From MRI and MRA to CT and PET, you are familiar with the acronyms, but do you know which scan to order when, and how to interpret the results? A review of the basics for the comprehensive ophthalmologist.
Clinical Updates: Glaucoma, Oculoplastics, Retina
No Evidence: A number of common clinical practices lack a strong evidence base—is it time to reexamine their role? Experts discuss how to assess the usefulness of some of these practices if clinical trial data are absent or conflicting.
Clinical Updates: Comprehensive, International, Uveitis